Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

bivalirudin

bivalirudin
Brand names: Angiomax
Form Strength
POWDER FOR INJECTION, INTRAVENOUS 250 mg


Additional Information:

HIT Guidelines:

Heparin induced thrombocytopenia (HIT) detection and management: See Guideline 916.5002

Bivalirudin dosing in patients with HIT (Heparin induced thrombocytopenia): See Protocol 916.6010

Other Guidelines:

Anticoagluation Management while on ECMO, see Protocol 922.5063

Adult ECMO Bivalirudin Dosing and Monitoring, see Protocol 901.6066

Pediatric Bivalirudin dosing with ECMO: Protocol 916.6004

LH Anticoagulant Management: Policy 900.3207

Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5681

Adult: For reversal, turn off the infusion (short half-life): See Reversal Guideline 900.5010

Pediatric: Reversal of bivalrudin: See Reversal Guideline 900.5866


Last updated: Oct. 14, 2021







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.